This study revealed the potential contribution of GPCPD1 deficiency in the choline metabolism pathway to HD pathogenesis and shed light on the potential therapeutic effects of citicoline in HD by normalizing metabolic patterns (Figure 7). Here, GPCPD1 is linked to Huntington disease.